anonymous
Guest
anonymous
Guest
BI has completely misjudged everything. Go to market was launched with the understanding that pharma was on the decline, and BI could blow up current positions, and everybody would be desperate to accept any position offered. Unfortunately for BI, pharma hasn't imploded. So many have left BI, and went elsewhere making between 115,000-130,000 base pay. Now they are offering 90-95,000 base pay for the rediculous HSBS positions. And everyone is turning these positions down! Hahahahahahaha! This company is beyond pathetic...